Last reviewed · How we verify
NCT07276009: ProPepsis
Probiotics in Functional Dyspepsia
NA trial testing Lactobacillus in Functional Dyspepsia in 60 participants. Not yet recruiting.
1 March 2026
Quick facts
| Lead sponsor | Nordic Biotic Sp. z o.o. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 5 January 2026 |
| Primary completion | 1 March 2026 |
| Estimated completion | 1 May 2026 |
Drugs / interventions tested
- Lactobacillus — full drug profile →
- Maltodextrin (Placebo) — full drug profile →
Conditions studied
- Functional Dyspepsia — all drugs for Functional Dyspepsia →
Sponsor
Nordic Biotic Sp. z o.o. — full company profile →
Who can join
Adults 18 to 65, any sex, with Functional Dyspepsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn whether a multi-strain probiotic can reduce digestive symptoms and improve quality of life in adults with functional dyspepsia. The main questions it aims to answer are: * Does the probiotic reduce symptoms such as fullness after meals, bloating, stomach discomfort, and early satiation? * Does the probiotic improve emotional well-being, including stress, anxiety, and mood? Researchers will compare the probiotic to a placebo (a look-alike capsule with no active ingredients) to see if the probiotic truly helps adults with functional dyspepsia. Participants will: * Take one capsule of the probiotic or placebo once daily before meals for 60 days * Complete questionnaires about their digestive symptoms at the start, 1 month, and 2 months * Complete surveys on stress, anxiety, depression, and quality of life at the start and 2 months * Attend scheduled study visits for checkups and assessments
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07276009
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lactobacillus
Trials testing the same drug.
- NCT06467942 — Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection · NA · recruiting
- NCT04756466 — Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly · NA · completed
Other recruiting trials for Functional Dyspepsia
Currently open trials in the same condition.
- NCT07442734 — Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms · NA · recruiting
- NCT07250308 — Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms · recruiting
- NCT07187492 — Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
- NCT07182890 — Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
- NCT07210294 — Press Needle on Body Acupuncture Points and Auricular Acupuncture Points on Functional Dyspepsia · NA · recruiting
Other Nordic Biotic Sp. z o.o. trials
Trials by the same sponsor.
- NCT07470645 — Effects of Probiotic Supplementation on Stress and Anxiety in Students · NA · not yet recruiting
- NCT06375668 — The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women · NA · completed
- NCT04907877 — Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients · NA · completed
- NCT05064930 — The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome · NA · completed
- NCT05013060 — The Efficacy of Sodium Butyrate and Probiotics in Patients With Irritable Bowel Syndrome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07276009 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nordic Biotic Sp. z o.o.
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07276009.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing